Cargando…
Novel Targets for Fast Antidepressant Responses: Possible Role of Endogenous Neuromodulators
The available medications for the treatment of major depressive disorder have limitations, particularly their limited efficacy, delayed therapeutic effects, and the side effects associated with treatment. These issues highlight the need for better therapeutic agents that provide more efficacious and...
Autores principales: | Camargo, Anderson, Rodrigues, Ana Lúcia S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7219953/ https://www.ncbi.nlm.nih.gov/pubmed/32440595 http://dx.doi.org/10.1177/2470547019858083 |
Ejemplares similares
-
Agmatine as a novel candidate for rapid-onset antidepressant response
por: Valverde, Ana Paula, et al.
Publicado: (2021) -
Neuromodulation for treatment-resistant depression: Functional network targets contributing to antidepressive outcomes
por: Idlett-Ali, Shaquia L., et al.
Publicado: (2023) -
Assessing Consciousness through Neurofeedback and Neuromodulation: Possibilities and Challenges
por: Vatrano, Martina, et al.
Publicado: (2023) -
Novel Molecular Targets of Antidepressants
por: Jarończyk, Małgorzata, et al.
Publicado: (2022) -
Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants
por: Browne, Caroline A., et al.
Publicado: (2013)